The Pharmasave Business Competition awards a third-year Waterloo School of Pharmacy student team a $5,000 prize for an innovative business model in the field of pharmacy.
Medication non-adherence is a concern globally, and often occurs unknowingly or by mistake. Dr. Tejal Patel, clinical associate professor at the University of Waterloo School of Pharmacy, is trying to improve medication management and assist older adults when taking their medication at home by correctly matching them with new innovative technologies.
A new study has found that although three-quarters of Ontario pharmacists can administer injections “vaccination deserts” do exist, areas with little to no access to pharmacist-administered vaccination sites.
Antimicrobial resistance ranks among the top ten global public health threats, according to the World Health Organization. Last week, landmarks across Canada were illuminated in blue to mark the end of World Antimicrobial Awareness Week (WAAW). On November 24th, the City of Kitchener’s Carl Zehr Square joined the University of Waterloo School of Pharmacy in the Go Blue for WAAW illumination program.
Have you ever dreamed of combining your love of travel with your ambitions? For Nikola Cubelic this dream was made a reality with the help of the Student Exchange Program (SEP) at Waterloo School of Pharmacy.
When pharmacy student MacKenzie Van Loon (Rx2023) learned about the Student Exchange Program (SEP), she immediately knew this was an experience she couldn’t pass up.
Richard Granholm (Rx2023) is not afraid of taking chances.
Growing up as an African Canadian woman in Ottawa, Jocelyn Bonti-Ankomah didn’t see many people who looked like her working in health care roles.
David Edwards, a professor in the University of Waterloo School of Pharmacy, was one of the new 2022 Fellows elected to the Canadian Academy of Health Sciences.
A new study reveals a connection between poverty and opioid-related hospitalization, emergency department visits and deaths in Canada. From 2000 to 2017, Canada's poorest residents were 3.8 times more likely to die of opioid-related causes than Canada's richest residents.